Is Genetic Medicine Making the World Less Fair?
By Laura Hercher,
The Nation
| 08. 23. 2019
New reproductive technologies promise to prevent serious genetic disease. What happens if only the rich can access them?
Call it the “ick” factor.
Stories like the 2018 bombshell out of China, of a scientist manipulating embryonic DNA to produce the world’s first genetically engineered human babies, make people uneasy, often in ways they find hard to define. Our fear of genetics is diffuse and visceral and surfaces in a range of dystopian visions, from experiments gone wrong, à la Frankenstein’s monster, to worlds dominated by genetically enriched super-people. But while our antennae are attuned to things distant, scary and futuristic, we may be missing the more real and immediate threat: Genetic medicine as we practice it today is poised to alter our concept of disease and responsibility in ways that will make the world fundamentally more unfair.
If you could use reproductive genetic technology to make sure that your child did not have a genetic disease, would you do it? That question is not science fiction anymore for many prospective parents. If you have an increased risk of breast and ovarian cancer because of a variant in your genes, there are now ways to make sure you...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...